CareMate® mBC is a treatment management app that has been designed to help people get the most out of their treatment while on therapy. CareMate® mBC can help remind people when to take their medication, be a health diary, help manage potential symptoms and allow the user to share all of these important updates in one easy report with their doctor.
The symptom tips found within the app are guides only to help manage symptoms – they do not replace the advice of a healthcare professional.
IBRANCE® Prescription Medicine. For the treatment of HR+, HER2- advanced breast cancer taken in combination with an aromatase inhibitor or fulvestrant.
IBRANCE® has risks and benefits. IBRANCE® (palbociclib 75 mg, 100 mg and 125 mg) Capsules and Tablets.
For Consumer Medicine Information refer to www.medsafe.govt.nz
IBRANCE® and CareMate® are registered trademarks. Pfizer New Zealand Limited. Auckland.
PP-IBR-NZL-0191-May 2022. TAPS NP18109